{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:39:19Z","timestamp":1790386759495,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001026","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000}}],"reference-count":123,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001026.pub2","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T20:42:15Z","timestamp":1559594535000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Antidepressants plus benzodiazepines for adults with major depression"],"prefix":"10.1002","author":[{"given":"Yusuke","family":"Ogawa","sequence":"first","affiliation":[{"name":"School of Public Health in the Graduate School of Medicine, Kyoto University; Department of Healthcare Epidemiology; Yoshida Konoe-cho, Sakyo-ku Kyoto Japan 606-8501"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Takeshima","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine\/School of Public Health; Department of Health Promotion and Human Behavior; Yoshida Konoe-cho, Sakyo-ku Kyoto Japan 606-8501"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hayasaka","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine\/School of Public Health; Department of Health Promotion and Human Behavior; Yoshida Konoe-cho, Sakyo-ku Kyoto Japan 606-8501"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aran","family":"Tajika","sequence":"additional","affiliation":[{"name":"Kyoto University Hospital; Department of Psychiatry; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine\/School of Public Health; Department of Health Promotion and Human Behavior; Yoshida Konoe-cho, Sakyo-ku Kyoto Japan 606-8501"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Streiner","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Psychiatry and Behavioural Neurosciences; 100 West 5th Street Room B-366 Hamilton ON Canada L8N 3K7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine\/School of Public Health; Department of Health Promotion and Human Behavior; Yoshida Konoe-cho, Sakyo-ku Kyoto Japan 606-8501"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD001026.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hup.470070206","article-title":"Clomipramine\/bentazepam combination in the treatment of major depressive disorders","volume":"7","author":"Calcedo Ordonez","year":"1992","journal-title":"Human Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD001026.pub2-BIB0002|cit2","first-page":"856","article-title":"Comparison of triazolam and placebo in the treatment of insomnia in depressed patients","volume":"36","author":"Dominguez","year":"1984","journal-title":"Current Therapeutic Research"},{"issue":"5","key":"10.1002\/14651858.CD001026.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00004714-198710000-00002","article-title":"Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients","volume":"7","author":"Fawcett","year":"1987","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD001026.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-0327(90)90125-R","article-title":"Challenging the amphetamine challenge test: report of an antidepressant treatment study","volume":"20","author":"Kravitz","year":"1990","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1002\/14651858.CD001026.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-1781(90)90080-O","article-title":"Antidepressant or antianxiety? A study of the efficacy of antidepressant medication","volume":"32","author":"Kravitz","year":"1990","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0007|cit6","first-page":"45","article-title":"Cortisol responses to imipramine combined treatments","volume":"8","author":"Feet","year":"1994","journal-title":"European Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001026.pub2-BIB0006|cit7","first-page":"77","article-title":"Gender differences in prolactin and aldosterone in primary non-agitated depressed patients and normal controls","volume":"7","author":"Feet","year":"1993","journal-title":"European Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1600-0447.1987.tb02812.x","article-title":"Comparison of the serum levels in primary non-agitated depressed out-patients treated with imipramine in combination with placebo, diazepam or dixyrazine","volume":"75","author":"Feet","year":"1987","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1600-0447.1985.tb02618.x","article-title":"A double blind study in out-patients with primary non-agitated depression treated with imipramine in combination with placebo, diazepam or dixyrazine","volume":"72","author":"Feet","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD001026.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00426739","article-title":"A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness","volume":"61","author":"Feighner","year":"1979","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0011|cit11","first-page":"61","article-title":"Doctor-patient concordance in a placebo-controlled trial of Limbitrol versus its components","volume":"14","author":"Jacobson","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00433497","article-title":"Limbitrol (amitriptyline plus chlordiazepoxide) revisited","volume":"75","author":"Rickels","year":"1981","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-0327(93)90103-Q","article-title":"Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant","volume":"28","author":"Nolen","year":"1993","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"10.1002\/14651858.CD001026.pub2-BIB0014|cit14","first-page":"587","article-title":"Comparative effects of Limbitrol and amitriptyline on sleep efficiency and architecture","volume":"47","author":"Scharf","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD001026.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-0327(99)00195-0","article-title":"Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression","volume":"61","author":"Londborg","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0016|cit16","unstructured":"Smith W Londborg PD Glaudin V Painter JR Treating anxiety and sleep disturbance as symptoms of depression and as side effects of specific serotonin reuptake inhibitors: low-dose clonazepam augmentation of fluoxetine. XXIst Collegium Internationale Neuro psychopharmacologicum; 1998 Jul 12-16; Glasgow, UK 1998"},{"issue":"10","key":"10.1002\/14651858.CD001026.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1176\/ajp.155.10.1339","article-title":"Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study","volume":"155","author":"Smith","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-0327(01)00352-4","article-title":"Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?","volume":"70","author":"Smith","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001026.pub2-BIB0019|cit19","first-page":"231","article-title":"Extended low-dose clonazepam cotherapy of fluoxetine in the treatment of depressed outpatients","volume":"3","author":"Smith","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0020|cit20","first-page":"1349","article-title":"Augmentation therapy of antidepressant and benzodiazepine in treatment of depression","volume":"9","author":"Yamaoka","year":"1994","journal-title":"Seishinka-Chiryo-Gaku"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0021|cit21","first-page":"230","article-title":"A double-blind controlled clinical trial of benzoctamin (Tacitin) and imipramine (Tofranil) in the treatment of 'internal heat' and its associated symptoms","volume":"65","author":"Ahmed","year":"1988","journal-title":"East African Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00421034","article-title":"The effects of hypnotics on imipramine treatment","volume":"39","author":"Ballinger","year":"1974","journal-title":"Psychopharmacology"},{"issue":"5-6","key":"10.1002\/14651858.CD001026.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/j.1552-4604.1978.tb02447.x","article-title":"The effect of diazepam on the recovery of endogenously depressed patients","volume":"18","author":"Bowen","year":"1978","journal-title":"Journal of Clinical Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD001026.pub2-BIB0024|cit24","first-page":"401","article-title":"Triazolam treatment of insomnia in depressed patients taking tricyclics","volume":"44","author":"Cohn","year":"1983","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0025|cit25","first-page":"213","article-title":"A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide","volume-title":"Advances in Biochemical Psychopharmacology: Typical and Atypical Antidepressants: Clinical Practice","volume":"32","author":"Dimitriou","year":"1982"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0026|cit26","first-page":"199","article-title":"Clinical studies with nomifensin","volume-title":"Zur Systematik, Provokation und Therapie depressiver Psychosen","author":"Eckmann","year":"1974"},{"issue":"5","key":"10.1002\/14651858.CD001026.pub2-BIB0027|cit27","first-page":"898","article-title":"Comparison of estazolam and placebo in the outpatient treatment of insomnia associated with major depression","volume":"49","author":"Ferguson","year":"1991","journal-title":"Current Therapeutic Research"},{"issue":"2","key":"10.1002\/14651858.CD001026.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/030006058501300202","article-title":"Comparison of Limbitrol (chlordiazepoxide\/amitriptyline) and amitriptyline alone as a single night-time dose for the treatment of depression with anxiety","volume":"13","author":"James","year":"1985","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3758\/BF03332199","article-title":"The effects of chronic treatment with amitriptyline and diazepam on electrodermal activity in neurotic outpatients","volume":"12","author":"Frith","year":"1984","journal-title":"Physiological Psychology"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00431822","article-title":"The relationship between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients","volume":"72","author":"Johnstone","year":"1981","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD001026.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S0033291700044081","article-title":"Neurotic illness and its response to anxiolytic and antidepressant treatment","volume":"10","author":"Johnstone","year":"1980","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0447.1985.tb08079.x","article-title":"Mianserin is better tolerated and more effective in depression than a nomifensin-clobazam combination: a double-blind study","volume":"320","author":"Levin","year":"1985","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/030006057500300311","article-title":"A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness","volume":"3","author":"Magnus","year":"1975","journal-title":"Journal of International Medical Research"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0034|cit34","first-page":"409","article-title":"Amytriptyline and chlordiazepoxide (Limbitrol) in depressive states in Nigerians: a double-blind study","volume":"1","author":"Morakinyo","year":"1970","journal-title":"African Journal of Medical Sciences"},{"issue":"5","key":"10.1002\/14651858.CD001026.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0011-393X(05)80182-1","article-title":"Fluoxetine\/bentazepam combination in the treatment of dysthymic disorders","volume":"55","author":"Otero","year":"1994","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0036|cit36","first-page":"30","article-title":"Drug treatment in depressive illness: amitriptyline and chlordiazepoxide in two neurotic populations","volume":"31","author":"Rickels","year":"1970","journal-title":"Disease of Nervous System"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0037|cit37","first-page":"468","article-title":"Differential drug effects in neurotic depression","volume":"31","author":"Rickels","year":"1970","journal-title":"Diseases of Nervous System"},{"issue":"6","key":"10.1002\/14651858.CD001026.pub2-BIB0038|cit38","first-page":"953","article-title":"Use of lormetazepam (Noctamid (R)) as a hypnotic in depressed patients: double-blind study on interactions with anti-depressant medication","volume":"38","author":"Runge","year":"1985","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0033-3182(73)71352-9","article-title":"Clinical response to amitriptyline and chlordiazepoxide-amitriptyline (Limbitrol) in anxiety-depressive states. A double-blind study","volume":"14","author":"Smith","year":"1973","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0040|cit40","first-page":"140","article-title":"A clinical study of insomnia","volume":"11","author":"Smith","year":"1975","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0041|cit41","first-page":"269","article-title":"Doxepin and amitriptyline-chlordiazepoxide combination in neurotic states","volume":"4","author":"Trappe","year":"1973","journal-title":"Psychiatrica Fennica"},{"issue":"6","key":"10.1002\/14651858.CD001026.pub2-BIB0042|cit42","first-page":"483","article-title":"Comparative clinical trial of chlordiazepoxide plus amitriptyline against maprotiline in depression with a component of anxiety","volume":"101","author":"Tsaras","year":"1981","journal-title":"Revue Medicale de la Suisse Romande"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1440-1819.2003.01099.x","article-title":"Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial","volume":"57","author":"Yamada","year":"2003","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"7","key":"10.1002\/14651858.CD001026.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0046|cit46","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423387.654001","volume-title":"American Psychiatric Association Practice Guideline for the Treatment of Major Depressive Disorder","author":"American Psychiatric Association","year":"2010"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0047|cit47","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007954","article-title":"Antidepressants versus placebo for depression in primary care","author":"Arroll","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1192\/bjp.128.5.486","article-title":"A comparison between the Hamilton Rating Scale and the Beck Inventory in the measurement of depression","volume":"128","author":"Bailey","year":"1976","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4088\/JCP.v67n0914","article-title":"What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?","volume":"67","author":"Bandelow","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2190\/VKBR-1AR6-9NBD-0N25","article-title":"Treatment of depression in older primary care patients in health maintenance organizations","volume":"27","author":"Bartels","year":"1997","journal-title":"International Journal of Psychiatry in Medicine"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15622970209150599","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 1: acute and continuation treatment of major depressive disorder","volume":"3","author":"Bauer","year":"2002","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00127-007-0204-1","article-title":"Prevalence of mental disorders based on general population surveys","volume":"42","author":"Baumeister","year":"2007","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001026.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0057|cit57","first-page":"477","article-title":"Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials","volume":"170","author":"Bhandari","year":"2004","journal-title":"Canadian Medical Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199510030-00008","article-title":"Benzodiazepines for depression? A review of the literature","volume":"10","author":"Birkenhager","year":"1995","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(97)00193-6","article-title":"Which patients receive antidepressants? A 'real world' telephone study","volume":"49","author":"Bouhassira","year":"1998","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-3956(93)90022-T","article-title":"Long-term drug treatment of panic disorder","volume":"27 Suppl 1","author":"Burrows","year":"1993","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(01)01262-8","article-title":"A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine","volume":"51","author":"Carpenter","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1176\/ajp.148.11.1512","article-title":"Follow-up and family study of anxious depression","volume":"148","author":"Clayton","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001026.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-5618.2010.00798.x","article-title":"Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials","volume":"12","author":"Correll","year":"2010","journal-title":"Bipolar Disorders"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/ajp.149.1.100","article-title":"Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology","volume":"149","author":"Coryell","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"6218","key":"10.1002\/14651858.CD001026.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/bmj.280.6218.910","article-title":"Systematic review of the benzodiazepines: guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam","volume":"280","author":"Committee on the Review of Medicines","year":"1980","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4088\/JCP.v68n0617","article-title":"Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials","volume":"68","author":"Crossley","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jclinepi.2013.03.009","article-title":"Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study","volume":"66","author":"Costa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1017\/S0033291700000805","article-title":"Psychotropic drug utilization and audit in two Italian psychiatric services","volume":"17","author":"Girolamo","year":"1987","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-0327(94)90101-5","article-title":"What factors predict discrepancies between self and observer ratings of depression?","volume":"31","author":"Domken","year":"1994","journal-title":"Journal of Affective Disorders"},{"issue":"9074","key":"10.1002\/14651858.CD001026.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","article-title":"Language bias in randomised controlled trials published in English and German","volume":"350","author":"Egger","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/030006058100900308","article-title":"Comparison of the therapeutic effect, tolerance and safety of ketazolam and diazepam administered for six months to out-patients with chronic anxiety neurosis","volume":"9","author":"Fabre","year":"1981","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.48.1.65","article-title":"Guillain-Barr\u00e9 syndrome following zimeldine treatment","volume":"48","author":"Fagius","year":"1985","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0447.2001.00148.x","article-title":"Benefits from mianserin augmentation of fluoxetine in patients with major depression nonresponders to fluoxetine alone","volume":"103","author":"Ferreri","year":"2001","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-0327(99)00175-5","article-title":"Treatment received by depressed patients in Japan and its determinants: naturalistic observation from a multi-center collaborative follow-up study","volume":"60","author":"Furukawa","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ije\/31.1.72","article-title":"Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses","volume":"31","author":"Furukawa","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analysis","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.schres.2010.10.016","article-title":"Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials","volume":"126","author":"Furukawa","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0091-3057(00)00221-5","article-title":"Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats","volume":"66","author":"Gomez","year":"2000","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1019604","article-title":"On the practice of clinical therapy with psychotropic drugs - retrospective investigation of physicians prescribing practices in a psychiatric hospital","volume":"13","author":"Grohmann","year":"1980","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0083|cit83","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0272989X08323298","article-title":"Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose","volume":"29","author":"Hansen","year":"2009","journal-title":"Medical Decision Making"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0087|cit87","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (update March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0088|cit88","first-page":"53","article-title":"Remission versus response: the new gold standard of antidepressant care","volume":"65 Suppl 4","author":"Keller","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"9896","key":"10.1002\/14651858.CD001026.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"7400","key":"10.1002\/14651858.CD001026.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-002-0999-0","article-title":"Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase ormianserin augmentation","volume":"161","author":"Licht","year":"2002","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD001026.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archfami.7.5.443","article-title":"Relapse of depression in primary care. Rate and clinical predictors","volume":"7","author":"Lin","year":"1998","journal-title":"Archives of Family Medicine"},{"issue":"9112","key":"10.1002\/14651858.CD001026.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(97)09528-7","article-title":"Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people","volume":"351","author":"Liu","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF00178503","article-title":"Chronic use of benzodiazepines and psychomotor and cognitive test performance","volume":"88","author":"Lucki","year":"1986","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD001026.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0278-5846(88)90023-1","article-title":"The effects on performance of two antidepressants, alone and in combination with diazepam","volume":"12","author":"Moskowitz","year":"1988","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0098|cit98","volume-title":"Cochrane Collaboration Handbook","author":"Mulrow","year":"1997"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0099|cit99","first-page":"153","article-title":"Diagnostic comorbidity and symptom co-occurrence: the Stirling County Study","volume-title":"Comorbidity of Mood and Anxiety Disorders","author":"Murphy","year":"1990"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001026.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/1047-2797(94)00112-7","article-title":"Risk of traffic accident injury after a prescription for a benzodiazepine","volume":"5","author":"Neutel","year":"1995","journal-title":"Annals of Epidemiology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0102|cit102","unstructured":"National Institute for Health and Care Excellence Depression in adults with a chronic physical health problem: treatment and management, 2009 www.nice.org.uk\/guidance\/CG90"},{"issue":"10","key":"10.1002\/14651858.CD001026.pub2-BIB0103|cit103","first-page":"382","article-title":"Benzodiazepine withdrawal: a review of the evidence","volume":"49","author":"Noyes","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001026.pub2-BIB0104|cit104","first-page":"627","article-title":"Th treatment of depression: prescribing practices of primary care physicians and psychiatrists","volume":"35","author":"Olfson","year":"1992","journal-title":"Journal of Family Practice"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/YIC.0b013e32833205a4","article-title":"Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study","volume":"25","author":"Papakostas","year":"2010","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0006-3223(95)00049-7","article-title":"Benzodiazepines as antidepressants - does GABA play a role in depression","volume":"38","author":"Petty","year":"1995","journal-title":"Biological Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD001026.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/aje\/136.7.873","article-title":"Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers","volume":"136","author":"Ray","year":"1992","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0109|cit109","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD001026.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1983.03340060045024","article-title":"Long-term diazepam therapy and clinical outcome","volume":"250","author":"Rickels","year":"1983","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0111|cit111","first-page":"193","article-title":"Indications and contraindications for chronic anxiolytic treatment: is there tolerance to the anxiolytic effect?","volume":"40","author":"Rickels","year":"1985","journal-title":"Advances in Biochemical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD001026.pub2-BIB0112|cit112","first-page":"246","article-title":"A comparison of self-reported versus clinician-related symptoms in depression","volume":"48","author":"Rush","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD001026.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/070674371105601105","article-title":"The utilization of antidepressants and benzodiazepines among people with major depression in Canada","volume":"56","author":"Sanyal","year":"2011","journal-title":"Canadian Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD001026.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/archpsyc.1978.01770350085008","article-title":"Benzodiazepines in depressive disorders","volume":"35","author":"Schatzberg","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1998.tb05973.x","article-title":"Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management","volume":"393","author":"Schweizer","year":"1998","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0116|cit116","volume-title":"Manual for the State-Trait Anxiety Inventory STAI (form Y) (\"Self-Evaluation Questionnaire\")","author":"Spielberger","year":"1983"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000118423","article-title":"Comparison between clinician-rated and self-reported depressive symptoms in Italian psychiatric patients","volume":"19","author":"Tondo","year":"1988","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1192\/bjp.184.5.386","article-title":"Global burden of depressive disorders in the year 2000","volume":"184","author":"Ustun","year":"2004","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001026.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0165-0327(91)90007-F","article-title":"Mental health intervention programs in primary care: their scientific basis","volume":"21","author":"Brink","year":"1991","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1002\/14651858.CD001026.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00023210-200418050-00003","article-title":"Residual effects of hypnotics: epidemiology and clinical implications","volume":"18","author":"Vermeeren","year":"2004","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1002\/14651858.CD001026.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-3956(89)90013-7","article-title":"Problems with the differentiation of anxiety and depression","volume":"23","author":"Wetzler","year":"1989","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0269881108097714","article-title":"Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review","volume":"24","author":"Whale","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD001026.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-0327(00)00254-8","article-title":"Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study","volume":"65","author":"Furukawa","year":"2001","journal-title":"Journal of Affective Disorders"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001026.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T20:59:09Z","timestamp":1628542749000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001026.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":123,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001026.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]}}}